Skip to content

Cilazapril

CARDIOVASCULAR SYSTEM

Also known as: cilazapril anhydrous, cilazapril hydrate, cilazapril monohydrate, cilazapril monohydrobromide, inhibace, vascace

ATC C09AA08ATC C09BA08

Data last refreshed: (DrugCentral release 2024-11-01)

Key facts

Cilazapril is a drug catalogued in DrugCentral. DrugCentral lists 1 molecular target, including ACE. Recorded indications include Hypertensive disorder.

  • Molecular targets: ACE (1 listed in DrugCentral).
  • Indications: Hypertensive disorder.
  • ATC code: C09AA08 (ACE inhibitors, plain).
  • Molecular formula: C22H31N3O5; molecular weight 417.51 g/mol.

Indications & contraindications

Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).

Indications (1)

  • Hypertensive disorder

Mechanism & targets

Molecular targets (1)

TargetGeneActionActivity
Angiotensin-converting enzymeACEinhibitorIC50 8.70

ATC classification

ATC codeTherapeutic hierarchy
C09AA08CARDIOVASCULAR SYSTEM › AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM › ACE INHIBITORS, PLAIN › ACE inhibitors, plain
C09BA08CARDIOVASCULAR SYSTEM › AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM › ACE INHIBITORS, COMBINATIONS › ACE inhibitors and diuretics

Reported adverse-event signals

Strongest FDA FAERS disproportionality signals (log-likelihood ratio). A signal is a statistical association in spontaneous reports, not proof that the drug causes the event.

MedDRA termLLR
Amaurosis fugax873.2
Ocular discomfort783.2
Haemorrhagic stroke775.1
Head discomfort739.1
Urinary tract disorder715.9
Blindness587.9
Generalised oedema564.2
Altered state of consciousness556.0
Haematemesis551.1
Eye pain548.0
Tinnitus509.8
Presyncope488.4

Chemical structure

Molecular formulaC22H31N3O5
Molecular weight417.51 g/mol
CAS number88768-40-5
InChIKeyHHHKFGXWKKUNCY-FHWLQOOXSA-N
PubChem CID56330
CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@H]1CCCN2CCC[C@H](N2C1=O)C(O)=O

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

What is Cilazapril used for?

DrugCentral lists the following indications for Cilazapril: Hypertensive disorder.

How does Cilazapril work?

Its molecular targets in DrugCentral include ACE (inhibitor).

What is the chemical formula of Cilazapril?

Cilazapril has the molecular formula C22H31N3O5 and a molecular weight of 417.51 g/mol.

Browse: all drugs starting with C · drug guides by category · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Quick facts

Status—
First approval—
Agency—
Targets1
Indications1
FormulaC22H31N3O5
DrugCentral ID641
Interactive profile